CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Acquisition or sale completed · Unregistered share sale · Auditor change · Change in control · Executive or director change · Shell status change · Regulation FD disclosure
- 4 Conversion Director acquired 7,187,500 shares (conversion)
- 4 Conversion 10% owner acquired 7,187,500 shares (conversion)
- 4 Insider Changes in Ownership
- 4 Conversion Director acquired 7,187,500 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Other acquisition Chief Executive Officer acquired 7,734,689 shares (other)
- 4 Grant or award Director acquired 30,062,778 shares (grant or award)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 25-NSE Other Notification of Removal from Listing
- 3 Insider Initial Statement of Ownership
Page 22 of 29 · 563 filings